Helping people who use drugs in rural Appalachia to reduce health risks

Engaging People Who Use Drugs in Harm Reduction Service Delivery: An Intravention to Reduce Risk of HIV, HCV, Overdose, and Injection-related Infections in Rural Appalachia

NIH-funded research University of Kentucky · NIH-11030486

This study is all about helping people who use drugs in rural Kentucky by using support from peers to make it easier for them to access important health services that can prevent overdose and diseases like hepatitis C and HIV.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Kentucky NIH-funded
Lab location1 site (Lexington, United States)
Project IDNIH-11030486 on NIH RePORTER

What this research studies

This research focuses on implementing a peer-driven approach to enhance harm reduction services for individuals who use drugs in two rural counties in Kentucky. The project aims to address critical health risks such as overdose, hepatitis C, and HIV by increasing the utilization of syringe service programs. By engaging peers who understand the challenges faced by these individuals, the initiative seeks to create a supportive environment that encourages participation and reduces stigma. The methodology includes outreach and education to overcome barriers that prevent people from accessing these vital services.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who use drugs and reside in rural Kentucky, particularly those at risk for overdose and infectious diseases.

Not a fit: Patients who do not use drugs or live outside the targeted rural Kentucky counties may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly reduce the rates of overdose, hepatitis C, and HIV among people who use drugs in rural areas.

How similar studies have performed: Previous research has shown that peer-driven interventions can effectively increase engagement in harm reduction services, suggesting a promising approach for this initiative.

Where this research is happening

Lexington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.